Treatment Satisfaction and Well-Being in Patients with Myopic Choroidal Neovascularization Treated with Ranibizumab in the REPAIR Study.

Treatment Satisfaction and Well-Being in Patients with Myopic Choroidal Neovascularization Treated with Ranibizumab in the REPAIR Study.

The Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen (REPAIR) trial was a prospective study exploring the efficacy and safety of intravitreal ranibizumab 0.5 mg using an individualized treatment regimen over 12 month...

Full description

Bibliographic Details
Main Authors: Winfried M Amoaku, Richard P Gale, Andrew J Lotery, Geeta Menon, Sobha Sivaprasad, Jennifer Petrillo, Jennifer Quinn
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4454435?pdf=render

Internet

http://europepmc.org/articles/PMC4454435?pdf=render

Similar Items